Sub-Group Analysis of a Phase III Trial Being Presented Today in a Poster Session at Digestive Disease Week LEXINGTON, Mass., May 21, 2013 (GLOBE... ...
http://www.bizwireexpress.com/showstoryGNW.php?storyid=310793ipla's stock has been gaining since March, after the company sweetened its offer to gain 100 per cent stake in South Africa-based Cipla Medpro. It... ...
http://www.smartinvestor.in/market/Features-176960-Featuresdet-Changing_global_strategy_outweighs_India_concerns_for_Cipla.htmFor MOXDUO® Advisory Committee Meeting SYDNEY and BEDMINSTER, N.J., May 17, 2013 /PRNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY)... ...
http://www.andhranews.net/Intl/Web/2-38.aspGlenmark Pharmaceuticals lost 2.13% to Rs 565 at 10:06 IST on BSE, with the stock sliding after recent rally triggered by the firm's step down... ...
http://www.indiainfoline.com/Markets/News/Glenmark-Pharma-drops-after-3-day-8.2-percent-rally/4869770752Cadila Healthcare rose 1.02% to Rs 844.35 at 09:28 IST on BSE after the company announced the launch of a drug for the treatment migraine in the... ...
http://www.indiainfoline.com/Markets/News/Cadila%20Healthcare%20in%20pink%20of%20health%20on%20launch%20of%20Zolmitriptan%20in%20US%20/4869568550